These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 23199790)

  • 41. Mendelian Randomization and Type 2 Diabetes.
    Swerdlow DI
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):51-7. PubMed ID: 26809778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using Mendelian randomization to understand and develop treatments for neurodegenerative disease.
    Storm CS; Kia DA; Almramhi M; Wood NW
    Brain Commun; 2020; 2(1):fcaa031. PubMed ID: 32954289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mendelian randomization studies: a review of the approaches used and the quality of reporting.
    Boef AG; Dekkers OM; le Cessie S
    Int J Epidemiol; 2015 Apr; 44(2):496-511. PubMed ID: 25953784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of Mendelian randomization studies incorporating all three genotypes.
    Palmer TM; Thompson JR; Tobin MD
    Stat Med; 2008 Dec; 27(30):6570-82. PubMed ID: 18767201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mendelian randomization as an instrumental variable approach to causal inference.
    Didelez V; Sheehan N
    Stat Methods Med Res; 2007 Aug; 16(4):309-30. PubMed ID: 17715159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interpretation of Mendelian randomization studies and the search for causal pathways in atherothrombosis: the need for caution.
    Ridker PM; Paynter NP; Danik JS; Glynn RJ
    Metab Syndr Relat Disord; 2010 Dec; 8(6):465-9. PubMed ID: 20818971
    [No Abstract]   [Full Text] [Related]  

  • 47. Mendelian Randomization.
    Birney E
    Cold Spring Harb Perspect Med; 2022 May; 12(4):. PubMed ID: 34872952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation in HDL-related genes and the association with cardiovascular disease: HDL particles as chameleons of lipoprotein metabolism.
    Kronenberg F
    J Intern Med; 2011 Aug; 270(2):128-31. PubMed ID: 21575086
    [No Abstract]   [Full Text] [Related]  

  • 49. Common pitfalls in drug target Mendelian randomization and how to avoid them.
    Gill D; Dib MJ; Cronjé HT; Karhunen V; Woolf B; Gagnon E; Daghlas I; Nyberg M; Drakeman D; Burgess S
    BMC Med; 2024 Oct; 22(1):473. PubMed ID: 39407214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reporting and guidelines for mendelian randomization analysis: A systematic review of oncological studies.
    Lor GCY; Risch HA; Fung WT; Au Yeung SL; Wong IOL; Zheng W; Pang H
    Cancer Epidemiol; 2019 Oct; 62():101577. PubMed ID: 31377572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
    Wang Y; Liang Y; Lu Q
    Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating Causal Relations between Genetic-Related Intermediate Endophenotype and Risk of Chronic Prostatitis: Mendelian Randomization Study.
    Zhang S; Xie X; Yu L; Jiang N; Wei X; Hu Y
    Oxid Med Cell Longev; 2022; 2022():4560609. PubMed ID: 36071874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mendelian randomization: a new approach to studying epidemiology in ESRD.
    Zoccali C; Testa A; Spoto B; Tripepi G; Mallamaci F
    Am J Kidney Dis; 2006 Feb; 47(2):332-41. PubMed ID: 16431263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mendelian randomisation and the goal of inferring causation from observational studies in the vision sciences.
    Plotnikov D; Guggenheim JA
    Ophthalmic Physiol Opt; 2019 Jan; 39(1):11-25. PubMed ID: 30628743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nature as a Trialist?: Deconstructing the Analogy Between Mendelian Randomization and Randomized Trials.
    Swanson SA; Tiemeier H; Ikram MA; Hernán MA
    Epidemiology; 2017 Sep; 28(5):653-659. PubMed ID: 28590373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mendelian randomization: application to cardiovascular disease.
    Timpson NJ; Wade KH; Smith GD
    Curr Hypertens Rep; 2012 Feb; 14(1):29-37. PubMed ID: 22161218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?
    Ebrahim S; Davey Smith G
    Hum Genet; 2008 Feb; 123(1):15-33. PubMed ID: 18038153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deep mendelian randomization: Investigating the causal knowledge of genomic deep learning models.
    Malina S; Cizin D; Knowles DA
    PLoS Comput Biol; 2022 Oct; 18(10):e1009880. PubMed ID: 36265006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One gene, many neuropsychiatric disorders: lessons from Mendelian diseases.
    Zhu X; Need AC; Petrovski S; Goldstein DB
    Nat Neurosci; 2014 Jun; 17(6):773-81. PubMed ID: 24866043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mendelian randomization as an ''instrumental variable'' in observational studies].
    Spoto B
    G Ital Nefrol; 2010; 27(4):338. PubMed ID: 20672230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.